Pfizer Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PFIZER BSE: 500680

₹3875.30

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #30 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Pfizer Limited (this stock)	17,729	24.1	17.2%	-24.8%	1.94%	71	40	6

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹17,628 Cr

EV / EBITDA

16.7x

EV / Sales

6.86x

Market cap / Sales

6.90x

Earnings yield

4.15%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 698 Cr, up 4.1% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 204 Cr, up 6.6% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	653	277	204	₹44.6900
March 31, 2026	629	269	200	₹43.6800
Dec. 31, 2025	645	192	142	₹31.0100
Sept. 30, 2025	642	255	189	₹41.3200
June 30, 2025	603	260	192	₹41.9100
March 31, 2025	592	426	331	₹72.3400
Dec. 31, 2024	538	172	128	₹
Sept. 30, 2024	589	215	158	₹34.6100
June 30, 2024	563	203	151	₹32.9400
March 31, 2024	547	244	179	₹22.3300
Dec. 31, 2023	540	176	130	₹27.1200
Sept. 30, 2023	575	201	149	₹32.5600
June 30, 2023	531	126	94	₹20.4400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	698	670	683	684	670	636	632	605	622	576	611	565	604
Operating revenue	653	629	645	642	603	592	589	563	547	540	575	531	573
Other income	45	41	38	42	67	45	43	42	75	36	36	33	31
Operating expenses	406	393	417	412	393	364	399	385	357	387	393	421	391
Operating profit	248	236	228	230	210	228	189	177	189	153	183	111	182
Operating profit margin	37.9%	37.5%	35.4%	35.8%	34.8%	38.4%	32.2%	31.5%	34.7%	28.3%	31.7%	20.8%	31.8%
Depreciation	14	15	14	14	14	16	15	15	14	18	15	16	26
Interest	1	2	2	2	3	3	2	2	7	3	3	3	3
Exceptional items, gain / (loss)	—	9	-58	—	—	173	—	—	—	8	—	—	-20
Profit before tax	277	269	192	255	260	426	215	203	244	176	201	126	165
Tax	72	69	50	66	68	95	57	52	65	46	52	32	35
Net profit	204	200	142	189	192	331	158	151	179	130	149	94	130
EPS	44.69	43.68	31.01	41.32	41.91	72.34	34.61	32.94	22.33	27.12	32.56	20.44	28.34
Net profit (TTM)	735	722	854	870	832	819	618	609	551	502	523	685	624
EPS (TTM)	160.70	157.92	186.58	190.18	181.80	162.22	117.00	114.95	102.45	108.46	114.27	149.70	136.37

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,520	976	722
March 31, 2025	2,281	1,016	768
March 31, 2024	2,193	746	551
March 31, 2023	2,425	824	624

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	2.3%	3.1%	2,708^†	—	2,374^†	2,526^†	2,674^†	2,320^†	2,336^†	2,249^†	2,094^†	2,123^†
Operating revenue	1.3%	2.4%	2,520	2,281	2,193	2,425	2,611^†	2,239^†	2,152^†	2,082^†	1,980^†	2,022^†
Other income	—	—	188^†	—	181^†	101^†	63^†	81^†	184^†	167^†	114^†	101^†
Operating expenses	—	—	1,616^†	—	1,558^†	1,616^†	1,775^†	1,526^†	1,579^†	1,516^†	1,480^†	—
Operating profit	3.8%	4.9%	904^†	—	635^†	809^†	836^†	712^†	573^†	565^†	501^†	—
Operating profit margin	—	—	35.9%^†	—	29.0%^†	33.4%^†	32.0%^†	31.8%^†	26.6%^†	27.2%^†	25.3%^†	—
Depreciation	—	—	58^†	—	62^†	106^†	115^†	109^†	103^†	71^†	66^†	—
Interest	—	—	9^†	—	15^†	13^†	10^†	15^†	11^†	1^†	1^†	1^†
Exceptional items, gain / (loss)	—	—	-49^†	—	8^†	33^†	0^†	0^†	0^†	0^†	0^†	130^†
Profit before tax	5.8%	7.8%	976	1,016	746	824	773^†	669^†	642^†	660^†	548^†	517^†
Tax	—	—	253^†	—	195^†	200^†	160^†	171^†	133^†	231^†	188^†	180^†
Net profit	5.0%	7.7%	722	768	551	624	613^†	498^†	509^†	429^†	360^†	337^†
EPS	5.0%	7.7%	157.92^†	—	102.45^†	136.37^†	133.90^†	108.76^†	111.30^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	35.9%^†	—	29.0%^†	33.4%^†	32.0%^†	31.8%^†	26.6%^†	27.2%^†	25.3%^†	—
EBIT margin	39.1%^†	—	34.7%^†	34.5%^†	30.0%^†	30.5%^†	30.4%^†	31.8%^†	27.7%^†	25.6%^†
PBT margin	38.7%	44.5%	34.0%	34.0%	29.6%^†	29.9%^†	29.9%^†	31.7%^†	27.7%^†	25.6%^†
Net margin	28.7%	33.6%	25.1%	25.7%	23.5%^†	22.2%^†	23.7%^†	20.6%^†	18.2%^†	16.7%^†
Interest coverage	103.92x^†	—	49.41x^†	62.54x^†	74.68x^†	45.26x^†	60.22x^†	512.56x^†	831.17x^†	539.36x^†
Dividend payout	22.2%^†	—	34.2%^†	47.7%^†	22.4%^†	303.4%^†	20.2%^†	—	—	—
Earnings retention	77.8%^†	—	65.8%^†	52.3%^†	77.6%^†	-203.4%^†	79.8%^†	—	—	—
Current ratio	6.06x	6.17x	—	—	—	—	—	—	—	—
Quick ratio	5.31x	5.33x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	17.2%	18.2%	—	—	—	—	—	—	—	—
Return on assets	14.7%	15.6%	—	—	—	—	—	—	—	—
Return on capital employed	22.9%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.51x	0.46x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	968	-562	-798	25	942
March 31, 2025	660	-71	-205	28	632
March 31, 2024	257	54	-235	19	238
March 31, 2023	356	-36	-346	65	291
March 31, 2022	667	-575	-181	15	652

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	4,922	4,203	4,157	2	0	3,803	627	103	136	473
March 31, 2025	4,911	4,217	4,172	2	0	3,513	570	495	172	476
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.